YVAX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
YVAX
Largest movements
- Cash -€12,492
down €12,492 (-86.5%), from €14,438 to €1,946
mainly Other debts (-€7,600) and Receivables within one year (-€4,200)
- Receivables within one year +€4,200
up €4,200 (+5.4%), from €77,689 to €81,889
- Other debts -€7,600
down €7,600 (-14.8%), from €51,520 to €43,920
- Financial income -€1,192
down €1,192 (-95.3%), from €1,250 to €58
- Gross operating margin +€724
up €724 (+71.9%), from -€1,007 to -€283
- Financial charges -€578
down €578 (-79.2%), from €729 to €151
- Other operating charges -€401
down €401 (-50.9%), from €788 to €387
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €190,282 | €181,991 | -€8,292 | -4.4% |
| Fixed assets | 21/28 | €48,156 | €48,156 | = | 0.0% |
| Financial fixed assets | 28 | €48,156 | €48,156 | = | 0.0% |
| Current assets | 29/58 | €142,127 | €133,835 | -€8,292 | -5.8% |
| Amounts receivable after more than one year | 29 | €50,000 | €50,000 | = | 0.0% |
| Other amounts receivable | 291 | €50,000 | €50,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €77,689 | €81,889 | +€4,200 | +5.4% |
| Other amounts receivable | 41 | €77,689 | €81,889 | +€4,200 | +5.4% |
| Cash at bank and in hand | 54/58 | €14,438 | €1,946 | -€12,492 | -86.5% |
| Total equity and liabilities | 10/49 | €190,282 | €181,991 | -€8,292 | -4.4% |
| Equity | 10/15 | €92,873 | €92,110 | -€763 | -0.8% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €6,200 | €6,200 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €24,673 | €23,910 | -€763 | -3.1% |
| Amounts payable | 17/49 | €97,409 | €89,880 | -€7,529 | -7.7% |
| Amounts payable within one year | 42/48 | €97,409 | €89,880 | -€7,529 | -7.7% |
| Trade debts | 44 | €45,889 | €45,961 | +€71 | +0.2% |
| Suppliers | 440/4 | €45,889 | €45,961 | +€71 | +0.2% |
| Other amounts payable | 47/48 | €51,520 | €43,920 | -€7,600 | -14.8% |
| Non-recurring operating income | 76A | €640 | - | -€640 | |
| Other operating charges | 640/8 | €788 | €387 | -€401 | -50.9% |
| Gross operating margin | 9900 | -€1,007 | -€283 | +€724 | +71.9% |
| Operating profit (loss) | 9901 | -€1,796 | -€670 | +€1,125 | +62.7% |
| Financial income | 75/76B | €1,250 | €58 | -€1,192 | -95.3% |
| Recurring financial income | 75 | €1,250 | €58 | -€1,192 | -95.3% |
| Financial charges | 65/66B | €729 | €151 | -€578 | -79.2% |
| Recurring financial charges | 65 | €729 | €151 | -€578 | -79.2% |
| Profit (loss) for the period before taxes | 9903 | -€1,274 | -€763 | +€511 | +40.1% |
| Profit (loss) for the period | 9904 | -€1,274 | -€763 | +€511 | +40.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,274 | -€763 | +€511 | +40.1% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.